Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc. Scilex Holding Company (Nasdaq: SCLX) confirmed a Dream Bowl 2026 Meme Coin claim process tied to a December 24, 2025 distribution. Eligible shareholders of record as of November 25, 2025 may claim allocated tokens any time after the December 24, 2025 distribution using the designated process at www.dreambowlcoin.com. The token program is powered by Datavault AI using encrypted blockchain infrastructure and real-world asset tokenization. The announcement positions the meme coin as a fusion of sports, digital assets, and shareholder perks. For corporate and product information, Scilex directs investors to its corporate and product websites.

#SCLX #SCLXW Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds Scilex Holding Company (Nasdaq: SCLX) announced a definitive agreement for the cash exercise of existing warrants to purchase an aggregate of 904,396 shares of common stock, generating approximately $20.3 million in gross proceeds before placement agent fees and offering expenses.In exchange for immediate cash exercise, the company will issue a new unregistered warrant to purchase up to 1,356,594 shares at an exercise price of $29.00 per share, exercisable immediately with a five-year term. The offering is expected to close on or about November 25, 2025, and net proceeds are planned for working capital and general corporate purposes.

#SCLX #SCLXW Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc. Scilex Holding Company (Nasdaq: SCLX) said Datavault AI (Nasdaq: DVLT) intends to voluntarily distribute Dream Bowl 2026 Meme Coins to Scilex record holders as of November 25, 2025, concurrent with Datavault AI's own eligible holders.Nasdaq told Datavault AI it will not make an announcement for Scilex about the distribution date. Distribution is conditional on recipients opting in, setting up a Data Vault® wallet, and providing documentation. Datavault AI's board may change the record date and will set the payment date within 60 days after the record date; payment is conditioned on the board not revoking the distribution.

#SCLX #SCLXW Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.

www.stocktitan.net/news/SCLX/scilex-holding...

Datavault AI Inc. (NASDAQ: DVLT) Announces Its Board of Directors Approved the Distribution of Dream Bowl Draft Meme Coins to All Eligible Scilex Holding Company and Datavault AI Shareholders with a S... Issuance will coincide with historic Dream Bowl AI driven draft and NFL Alumni mentorship program...

#DVLT #SCLX Dream Bowl Draft Meme Dividend
ex-dividend date to acquire is 11/24
www.globenewswire.com/news-release...

Datavault AI Inc. (NASDAQ: DVLT) Announces Its Board of Directors Approved the Distribution of Dream Bowl Draft Meme Coins to All Eligible Scilex Holding Company and Datavault AI Shareholders with a S... Issuance will coincide with historic Dream Bowl AI driven draft and NFL Alumni mentorship program...

#DVLT #SCLX Dream Bowl Draft Meme Dividend
ex-dividend date to acquire is 11/24
www.globenewswire.com/news-release...

Datavault AI Inc. (NASDAQ: DVLT) Announces Its Board of Directors Approved the Distribution of Dream Bowl Draft Meme Coins to All Eligible Scilex Holding Company and Datavault AI Shareholders with a S... Issuance will coincide with historic Dream Bowl AI driven draft and NFL Alumni mentorship program...

#DVLT #SCLX Dream Bowl Draft Meme Dividend
ex-dividend date to acquire is 11/24
www.globenewswire.com/news-release...

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug inform... PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating...

#DVLT #SCLX Scilex has acquired a worldwide exclusive license, including sublicense rights, to Datavault AI's proprietary AI technology.
www.globenewswire.com/news-release...

Datavault AI Secures $150 Million Strategic Investment from Scilex Holding Company to Build Supercomputer and Launch Independent Data Exchanges in the US Datavault AI (Nasdaq: DVLT) has secured a strategic $150 million investment from Scilex Holding Company (Nasdaq: SCLX), structured in two tranches: an initial $8.07 million closing on September 26, 2025, and a second tranche of $141.93 million pending stockholder approval. The transaction, executed in Bitcoin at Coinbase's spot rate, will provide growth capital for Datavault's supercomputing infrastructure and data exchange expansion.Under the agreement, Scilex will receive 278.9 million DVLT shares at $0.5378 per share, with initial 15 million shares at first closing and the remainder as pre-funded warrants. The investment aims to strengthen Datavault's position in the $35.69 billion life sciences analytics market and leverage partnerships with Brookhaven National Laboratory and IBM WatsonX.

#DVLT #SCLX Datavault AI Secures $150 Million Strategic Investment from Scilex Holding Company to Build Supercomputer and Launch Independent Data Exchanges in the US

www.stocktitan.net/news/DVLT/datavault-ai-s...

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI Scilex Holding Company (Nasdaq: SCLX) has announced a strategic $150 million Bitcoin investment in Datavault AI Inc. (Nasdaq: DVLT). The investment will provide Datavault with growth capital to enhance its supercomputing infrastructure and expand data exchanges.Under the agreement, Scilex will receive up to 278,914,094 shares of Datavault common stock at an effective price of $0.5378 per share. The transaction will occur in two tranches, with 15 million shares issued at initial closing and the remainder through a pre-funded warrant pending stockholder approval.The partnership aims to capitalize on the growing biotech data monetization market, projected to reach $30-50 billion by 2024. Scilex will gain board representation rights, with the ability to nominate two directors while maintaining 10% ownership or one director at 5-10% ownership.

#SCLX #SCLXW Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding will raise $200 million through an additional share issue to purchase #BTC for its balance sheet.

#SCLX

Just In: ( NASDAQ: #SCLX ) Semnur Pharmaceuticals, Inc. ("Semnur"), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, "Scilex"), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal Scilex Holding Company (SCLX) announced a publication highlighting GLOPERBA's dosing adjustments in a peer-reviewed journal. GLOPERBA is the first liquid oral colchicine for gout flare prophylaxis, enabling precision dosing for patients with renal impairment. The study reveals that patients with renal issues taking standard colchicine formulations often receive sub-optimal or excessive doses. The research demonstrates that GLOPERBA's liquid format allows for more precise dosing: 0.48 mg for moderate renal impairment and 0.3 mg for severe renal impairment, leading to better therapeutic outcomes. This is particularly significant as over 70% of gout patients have comorbid conditions requiring dose adjustments.

#SCLX #SCLXW Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

www.stocktitan.net/news/SCLX/scilex-holding...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with declining money flow, Wed Apr 16th - #WNW #TRST #QRHC #WTI #SHCO #NVRO #MAX #KLC #FRGE #DTC #ZD #VREX #SCLX #ADVM #CADL #DOYU #GREE #IMTX #KIDS #PDLB - More: crystalequityresearch.com/SmCpStr/ - #smallcap

FDA Approval: Scilex's Revolutionary Liquid Heart Drug Secures Rare Disease Status First-ever liquid colchicine targets rare heart condition with potential 7-year market exclusivity. Breakthrough formulation offers unique dosing advantages. Full analysis inside.

#SCLX Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

www.stocktitan.net/news/SCLX/scilex-holding...

Just In: ( NASDAQ: #SCLX ) SCLX announced stock split 1-35

Scilex's Strategic 1-for-35 Reverse Split Targets Nasdaq Compliance: What's Next Scilex reduces shares from 243M to 6.9M through reverse split, effective April 15. Strategic move aims to maintain Nasdaq listing. See full impact analysis.

#SCLX Scilex Holding Company Announces 1-for-35 Reverse Stock Split

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication Scilex Holding Company (Nasdaq: SCLX) has announced that the U.S. FDA has acknowledged the submission of their Supplemental New Drug Application (SNDA) for ELYXYB® in the indication of acute pain. Scilex is a revenue-generating company focused on developing and commercializing non-opioid pain management products for both acute and chronic pain. The company is also exploring opportunities in neurodegenerative and cardiometabolic diseases through a proposed joint venture with IPMC Company.

#SCLX Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Extends Debt Maturity to 2025, Strengthens Financial Position with Oramed Note Amendment Scilex Holding Company secures extension of Senior Secured Promissory Note maturity to December 2025, reinforcing its non-opioid pain management business development strategy.

#SCLX Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Files FDA Application for ELYXYB Pain Drug Following Successful Clinical Trial Results Scilex's ELYXYB non-opioid pain solution shows superior efficacy in dental surgery study. Drug targets $3B acute pain market with enhanced bioavailability technology.

#SCLX Scilex Holding Company Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB® in Acute Pain Indication

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Regains Nasdaq Compliance Following Q3 Filing, Expands Into Neurodegenerative Treatment Scilex Holding Company files Q3 2024 report, anticipates Nasdaq compliance confirmation, and announces strategic joint venture for neurodegenerative disease treatments.

#SCLX Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex's ZTlido Pain Patch Shows Superior Results in Reducing Opioid Use vs Generic Alternative New study reveals ZTlido® helped 51.9% of patients decrease or stop opioid use, significantly outperforming generic lidocaine patch in comprehensive pain management analysis.

#SCLX Scilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex (SCLX) Fast-Tracks $13.2M Debt Payment to Oramed, Strengthens Financial Position Scilex makes strategic early payment on senior secured note to Oramed, demonstrating financial strength. Final payment scheduled for March 2025 to fully retire debt.

#SCLX Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces $17 Million Registered Direct Offering Scilex Holding Company (SCLX) has announced a $17 million registered direct offering, involving the sale of 26,355,347 common stock shares and 2,401,132 pre-funded warrants. The offering includes common warrants to purchase up to 57,512,958 shares. The combined offering price is $0.59 per share for common stock and $0.5899 for pre-funded warrants.The pre-funded warrants will have a $0.0001 exercise price and immediate exercisability, while common warrants will have a $0.6490 exercise price, becoming exercisable after six months. The offering is expected to close around December 13, 2024. Additionally, an investor agreed to exercise outstanding warrants for 1,764,706 shares at $0.59, providing approximately $1.0 million in gross proceeds.

#SCLX Scilex Holding Company Announces $17 Million Registered Direct Offering

#offering #stocks #investing

www.stocktitan.net/news/SCLX/scilex-holding...

#SCLX Scilex Holding Company Announces Receipt of Notice from Nasdaq

www.stocktitan.net/news/SCLX/scilex-holding...